The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants

• Verfasst von: Buss, Meghan C. [VerfasserIn]
• Verfasst von: Pfister, Stefan [VerfasserIn]
• Titel: The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants
• Verf.angabe: Meghan C. Buss, Marc Remke, Juhyun Lee, Khanjan Gandhi, Matthew J. Schniederjan, Marcel Kool, Paul A. Northcott, Stefan M. Pfister, Michael D. Taylor, and Robert C. Castellino
• Umfang: 15 S.
• Fussnoten: Gesehen am 21.07.2017
• Titel Quelle: Enthalten in: Oncogene
• Jahr Quelle: 2015
• Band/Heft Quelle: 34(2015), 9, S. 1126-1140
• ISSN Quelle: 1476-5594
• DOI: doi:10.1038/onc.2014.37
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1561085715

Abstract

Recent studies suggest that medulloblastoma, the most common malignant brain tumor of childhood, is comprised of four disease variants. The WIP1 oncogene is overexpressed in Group 3 and 4 tumors, which contain medulloblastomas with the most aggressive clinical behavior. Our data demonstrate increased WIP1 expression in metastatic medulloblastomas, and inferior progression-free and overall survival of patients with WIP1 high-expressing medulloblastoma. Microarray analysis identified up-regulation of genes involved in tumor metastasis, including the G protein-coupled receptor CXCR4, in medulloblastoma cells with high WIP1 expression. Stimulation with the CXCR4 ligand SDF1ααactivated PI-3 kinase signaling, and promoted growth and invasion of WIP1 high-expressing medulloblastoma cells in a p53-dependent manner. When xenografted into the cerebellum of immunodeficient mice, medulloblastoma cells with stable or endogenous high WIP1 expression exhibited strong expression of CXCR4 and activated AKT in primary and invasive tumor cells. WIP1 or CXCR4 knock-down inhibited medulloblastoma growth and invasion. WIP1 knock-down also improved the survival of mice xenografted with WIP1 high-expressing medulloblastoma cells. WIP1 knock-down inhibited cell surface localization of CXCR4 by suppressing expression of the G protein receptor kinase 5, GRK5. Restoration of wild-type GRK5 promoted Ser339 phosphorylation of CXCR4 and inhibited the growth of WIP1-stable medulloblastoma cells. Conversely, GRK5 knock-down inhibited Ser339 phosphorylation of CXCR4, increased cell surface localization of CXCR4, and promoted the growth of medulloblastoma cells with low WIP1 expression. These results demonstrate cross-talk among WIP1, CXCR4, and GRK5, which may be important for the aggressive phenotype of a subclass of medulloblastomas in children.